A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers

NCT01858545 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Foot Ulcer, Diabetic

Interventions

DEVICE: MatriStem
DEVICE: Cellular Dermal Replacement Tissue

Sponsor

Integra LifeSciences Corporation